• > Letters and Urgent Communications 2012
Investors in People (Bronze)

Letters and Urgent Communications 2012

  • HSS(MD) 18/2012 21 May 2012 (PDF 278 KB)
    Emergency Planning: Patient Group Directions for administration of medicines by authorised Healthcare Personnel to patients exposed to suspected Biological or Radiological Agents

  • HSS(MD) 16/2012 30 April 2012 (PDF 333 KB)
    Water Sources and Potential Pseudomonas Aeruginosa contamination of taps and water systems - advice for Augmented Care Units (including neonatal units caring for babies at levels 1, 2 & 3)
  • HSS(MD) 15/2012 6 April 2012 (PDF 194 KB)
    Pseudomonas Update:
    1. Interim Report on the Independent Review of Incidents of Pseudomonas Aeruginosa Infection in Neonatal Units in Northern Ireland and:
    2. Water Sources and Potential Pseudomonas Aeruginosa contamination of taps and water systems - advice for Augmented Care Units
  • HSS(MD) 7/2012 17 February 2012 (PDF 172 KB)
    Suspension of Marketing Authorisation: Teva Levothyroxine 100 microgram tablets and Numark Levothyroxine 100 microgram tablets - Letter from Sir Gordon Duff, Chairman of the Commission of Human Medicines and advice from MHRA
Quick Links